# Chad Waite

> Chad Waite is a funding round investor at OVP Venture Partners backing Software and Biotechnology. See 17 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [OVP Venture Partners](https://shizune.co/investors/profile/ovp-venture-partners)
- Total investments: 17
- Last investment: Mar 2014
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/chad-waite/5/336/3b7

Chad Waite is a funding round investor at OVP Venture Partners focused on Software and Biotechnology. Chad Waite joined OVP Venture Partners in 1987 and focuses on investments in the digital biology, and network security sectors. His investments include 4thPass, Accelerator, Adapx, Airgo Networks, Boston Beer, Cardima, CellPro, Complete Genomics, Corixa, Filenet, GenoLogics, Limerick BioPharma, Loudeye Technologies, NanoString, Napera Networks,ProTools, Quantum Medical, Raytel Medical, Returns Online, Rosetta Inpharmatics, SafeHarbor, Saros, Seattle Genetics, SignalSoft, Syntellect, Vantos, Verdezyne, Verity, and WatchGuard. He currently serves on the Board of Directors of Accelerator, Adapx, Aggregate Knowledge, NanoString, Symform, Verdezyne and The W Fund, and is a Board Observer to Talyst.Prior to joining OVP, Chad was a General Partner at Hambrecht & Quist Venture Partners where he focused on investments in IT and life sciences. Prior to H&Q, he was in marketing and sales management at Cobe Laboratories, Inc. in its cardiovascular medical products division.Chad received his BA in History from Kenyon College and his MBA from Harvard Business School. He is a Trustee at Kenyon College and has also served as a board member of the NVCA. He is the proud father of three grown children, is an avid cyclist and snowboarder, and loves fine wine.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 12% |
| Biotechnology | 2 | 12% |
| CRM | 1 | 6% |
| Apps | 1 | 6% |
| Banking | 1 | 6% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 5 | 29% |
| Series A | 3 | 18% |
| Series B | 2 | 12% |
| Series C | 1 | 6% |
| Series D | 1 | 6% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Verdezyne | Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercialfermentation processes for the production of petrochemical replacements. | $48M |  | Mar 28, 2014 |  |
| Adapx | Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M |  | Apr 11, 2013 |  |
| NanoString Technologies | NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.NanoString's products are based on a novel digital molecularbarcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. | $15.3M | Series E | Dec 03, 2012 |  |
| Adapx | Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $3M |  | Jul 30, 2012 |  |
| Symform | Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $11M | Series B | Apr 25, 2012 |  |
| Symform | Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $2M |  | Jan 24, 2012 |  |
| NanoString Technologies | NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.NanoString's products are based on a novel digital molecularbarcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna®, its first in vitro diagnostic product for prognosis of early stage breast cancer. | $20M | Series D | Nov 07, 2011 |  |
| Adapx | Adapx offers software that turns natural speech, sketches, and handwriting into data for Microsoft Office and other back-end systems. By simply speaking and writing, teams get instant access to structured data collected on paper, touchscreens, mobile devices, and wall displays. A range of enterprises and agencies speed workflows and reduce risk byusing Capturx to bypass data transcription from paper and cumbersome keyboard- and menu-driven interfaces.Adapx was formerly known as Natural Interaction Systems. The company was founded in 1999 and is based in Seattle, Washington. | $5M |  | May 20, 2011 |  |
| Symform | Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $4M |  | Jul 01, 2010 |  |
| Symform | Symform develops cost effective solutions to large scale distributed data management problems. The Symform Cooperative Storage Cloud is a solution that combines the best practices of disaster recovery, data security and distributed networking using the power of Internet.The big idea is simple: Give local storage, get online storage. Memberscontribute unused server space equal to the amount they consume in the storage cloud. Symform handles the day-to-day management of network security and administration of the storage cloud. | $1.5M | Series A | Apr 27, 2009 |  |

10 of 17 investments shown.

## Co-investors
- [Paladin Capital Group](https://shizune.co/investors/profile/paladin-capital-group) — VC Fund, 4 deals together
- [Longworth Venture Partners](https://shizune.co/investors/profile/longworth-venture-partners) — VC Fund, 3 deals together
- [Pelion Venture Partners](https://shizune.co/investors/profile/pelion-venture-partners) — VC Fund, 3 deals together
- [Alexandria Real Estate Equities](https://shizune.co/investors/profile/alexandria-real-estate-equities) — VC Fund, 2 deals together
- [Amgen Ventures](https://shizune.co/investors/profile/amgen-ventures) — VC Fund, 2 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 2 deals together

## About OVP Venture Partners

VC Fund · Seattle, United States

OVP Venture Partners is a venture capital firm specializing in early-stage technology-based companies.

5 contacts available at OVP Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Gordon Steele | Board Member | https://shizune.co/investors/profile/gordon-steele-2 |
| Bill Funcannon | Controller, Managing Director & CFO | https://shizune.co/investors/profile/bill-funcannon-2 |
| Chad Waite | Managing Director | https://shizune.co/investors/profile/chad-waite-2 |
| Dick Strayer | Founder & CEO | https://shizune.co/investors/profile/dick-strayer-68c9 |
| Gerry Langeler | Managing Director | https://shizune.co/investors/profile/gerry-langeler |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Chad Waite invest in?

Chad Waite invests primarily in Software, Biotechnology and CRM startups, most often at Funding Round and Series A stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chad Waite last invest?

The most recent investment recorded for Chad Waite closed in Mar 2014. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co